Ni, M., Yang, A., Su, Y., Yang, Z., Hu, Y., Huang, J. J., Chen, M., Li, N., Xiao, X., Liang, G., Liu, Y., Wang, X., An, X. (2026). Neoadjuvant toripalimab combined with inetetamab, pertuzumab, and nab-paclitaxel in HER2-positive breast cancer (TORCH): A phase II trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e12658